Performance of Abbott ARCHITECT® CORIE-M™ assay for the US

被引：0
|
作者：
Paradowski, M.
Grasso, K.
Demers, L.
Heffner, J.
Dubler, R.
Kramer, C.
Hoffman, A.
Herrmann, R.
Bartko, K.
Galvani, K.
Fei, H.
Li, C.
Rios, W.
Williams, G.
Mohammad, A. A.
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
[2] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA
[3] Wisconsin Co Biomed Res, Milwaukee, WI USA
[4] Univ Texas, Med Branch, Galveston, TX 77550 USA
来源：
CLINICAL CHEMISTRY | 2007年 / 53卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
B-18
引用
收藏
页码：A58 / A58
页数：1
相关论文
共 50 条
  • [21] EVALUATION OF COPPER ASSAY IN SERUM ON THE ABBOTT ARCHITECT ANALYZER
    Coric, J.
    Panjeta, M.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S753 - S753
  • [22] Performance evaluation and clinical experience with the Abbott ARCHITECT STAT Troponin-I assay
    Black, M
    Lam, Q
    Spilsbury, H
    Youdell, O
    Schneider, HG
    CLINICA CHIMICA ACTA, 2005, 355 : S88 - S88
  • [23] Assay performance evaluation of a new immunoassay analyzer, the Abbott ARCHITECT® i1000.
    Patel, R
    Wiviott, M
    Chorazy, J
    Bell, S
    Spear, K
    Badertscher, J
    Lu, M
    Tang, M
    Massie, D
    CLINICAL CHEMISTRY, 2001, 47 (06) : A117 - A117
  • [24] Evaluation of an assay in development for tacrolimus on the Abbott ARCHITECT® analyzer
    Baugher, B. W.
    Drengler, S.
    Rahn, T.
    Ramp, J.
    Liao, M.
    Wong, P. Y.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A59 - A59
  • [25] Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay
    Hamilton, Fergus
    Muir, Peter
    Attwood, Marie
    Vipond, Alan Noela Barry
    Hopes, Richard
    Moran, Ed
    Maskell, Nick
    Warwick, Deborah
    Albur, Mahableshwar
    Turner, Jonathan
    MacGowan, Alasdair
    Arnold, David
    JOURNAL OF INFECTION, 2020, 81 (06) : E7 - E9
  • [26] Evaluation of an assay in development for Digoxin on the Abbott ARCHITECT analyzer
    Baugher, B. W.
    Cantrell, A.
    Wilson, D. H.
    Liao, M.
    Yip, P.
    Wang, Y.
    Wong, P. Y.
    Fontanals, M. L.
    Llop, T.
    Villen, E.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A16 - A17
  • [27] Evaluation of Levetiracetam ARK Assay on the Abbott ARCHITECT Analyser
    Outeda-Macias, M.
    Salvador-Garrido, P.
    Martinez-Lopez, L. M.
    Martin-Herranz, I
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 730 - 730
  • [28] Analytical multisite evaluation of the Abbott ARCHITECT Tacrolimus assay
    Maine, G. T.
    Kahn, S. E.
    Vazquez, D.
    Meyer, P.
    Dickson, D.
    Schmidt, E.
    Castellani, W. J.
    Pederson, E. C.
    Edwards, M.
    Haverstick, D. M.
    Yabut, O.
    CLINICAL BIOCHEMISTRY, 2008, 41 (14-15) : 1278 - 1278
  • [29] Performance evaluation of the re-standardized Abbott Architect anti-HBs assay
    Wong, Ann H.
    Ho, Yolanda I. I.
    Lai, Raymond W. M.
    JOURNAL OF CLINICAL VIROLOGY, 2019, 111 : 1 - 3
  • [30] T-Uptake assay on the abbott ARCHITECT® iSYSTEM
    Engle, T. L.
    Shull, B. C.
    Bowman, N.
    Verdun, R.
    Arabshahi, L.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A89 - A89
12345